Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) was the recipient of a large decrease in short interest during the month of December. As of December 29th, there was short interest totalling 12,798,732 shares, a decrease of 17.3% from the December 15th total of 15,484,326 shares. Based on an average daily volume of 1,613,629 shares, the short-interest ratio is presently 7.9 days. Currently, 7.2% of the company’s stock are sold short.

In other news, SVP James Hewitt sold 36,796 shares of the stock in a transaction on Friday, December 1st. The stock was sold at an average price of $14.11, for a total transaction of $519,191.56. Following the completion of the sale, the senior vice president now owns 181,766 shares in the company, valued at approximately $2,564,718.26. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Brian Farley sold 5,000 shares of the stock in a transaction on Thursday, December 14th. The shares were sold at an average price of $14.35, for a total value of $71,750.00. Following the sale, the executive vice president now owns 191,607 shares of the company’s stock, valued at approximately $2,749,560.45. The disclosure for this sale can be found here. In the last quarter, insiders have sold 56,796 shares of company stock valued at $804,842. Company insiders own 0.91% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its position in shares of Allscripts Healthcare Solutions by 1.2% in the 2nd quarter. Vanguard Group Inc. now owns 14,824,640 shares of the software maker’s stock valued at $189,162,000 after acquiring an additional 181,721 shares during the period. Dimensional Fund Advisors LP grew its position in Allscripts Healthcare Solutions by 3.7% during the 3rd quarter. Dimensional Fund Advisors LP now owns 9,508,667 shares of the software maker’s stock worth $135,308,000 after purchasing an additional 337,382 shares during the period. Fiduciary Management Inc. WI grew its position in Allscripts Healthcare Solutions by 0.6% during the 2nd quarter. Fiduciary Management Inc. WI now owns 6,083,536 shares of the software maker’s stock worth $77,626,000 after purchasing an additional 38,426 shares during the period. State Street Corp grew its position in Allscripts Healthcare Solutions by 28.6% during the 2nd quarter. State Street Corp now owns 5,975,551 shares of the software maker’s stock worth $76,251,000 after purchasing an additional 1,330,721 shares during the period. Finally, Fuller & Thaler Asset Management Inc. grew its position in Allscripts Healthcare Solutions by 1.0% during the 3rd quarter. Fuller & Thaler Asset Management Inc. now owns 5,062,035 shares of the software maker’s stock worth $72,033,000 after purchasing an additional 49,823 shares during the period.

Allscripts Healthcare Solutions (NASDAQ MDRX) opened at $16.03 on Friday. The company has a debt-to-equity ratio of 1.20, a current ratio of 0.98 and a quick ratio of 0.98. Allscripts Healthcare Solutions has a 12-month low of $11.01 and a 12-month high of $16.12. The stock has a market capitalization of $2,900.00, a price-to-earnings ratio of -13.82, a P/E/G ratio of 2.17 and a beta of 1.32.

Several analysts have recently commented on the company. Robert W. Baird increased their price objective on Allscripts Healthcare Solutions from $16.00 to $17.00 and gave the company an “outperform” rating in a report on Friday, November 3rd. KeyCorp reiterated a “hold” rating on shares of Allscripts Healthcare Solutions in a report on Friday, October 27th. Zacks Investment Research lowered Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a report on Wednesday, November 8th. BidaskClub upgraded Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a report on Wednesday, December 20th. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $17.00 target price on shares of Allscripts Healthcare Solutions in a research report on Wednesday, September 27th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and twelve have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $15.53.

COPYRIGHT VIOLATION NOTICE: This report was published by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/01/13/allscripts-healthcare-solutions-inc-mdrx-short-interest-update.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.